Related Experiment Video

Updated: Jun 5, 2026

Experimental and Imaging Techniques for Examining Fibrin Clot Structures in Normal and Diseased States
07:09

Experimental and Imaging Techniques for Examining Fibrin Clot Structures in Normal and Diseased States

Published on: April 1, 2015

Hemostatic disorders in type 1 diabetes mellitus

Giovanni Targher1, Michel Chonchol, Giacomo Zoppini

  • 1Section of Endocrinology, Department of Medicine, University of Verona, Verona, Italy. giovanni.targher@univr.it

Seminars in Thrombosis and Hemostasis
|January 21, 2011
PubMed

Insights

Patients with type 1 diabetes mellitus experience a procoagulant state, increasing risks for vascular complications. Understanding these effects on coagulation and fibrinolysis is crucial for managing cardiovascular and microvascular disease.

Area of Science:

  • Endocrinology
  • Hematology
  • Vascular Biology

Background:

  • Type 1 diabetes mellitus (T1DM) is associated with increased risk of vascular complications.
  • Coagulation and fibrinolysis play critical roles in vascular health.
  • The specific impact of T1DM on hemostasis requires further elucidation.

Purpose of the Study:

  • To review the adverse effects of T1DM on coagulation and fibrinolysis.
  • To highlight the association between procoagulant imbalance and vascular complications in T1DM.
  • To emphasize the interplay between endothelial function, hemostatic factors, and platelets in T1DM.

Main Methods:

  • Literature review of current knowledge on T1DM and hemostasis.
  • Focus on data from large prospective studies.
  • Analysis of interactions between coagulation, fibrinolysis, platelets, and endothelial integrity.

Main Results:

  • T1DM patients exhibit a proinflammatory/procoagulant condition.
  • Key findings include increased platelet adhesiveness and coagulation activation.
  • Decreased plasma fibrinolytic potential is observed in T1DM.

Conclusions:

  • Procoagulant imbalance in T1DM is strongly linked to chronic vascular complications.
  • Understanding hemostatic changes in T1DM is vital for predicting cardiovascular and microvascular risks.
  • Further research is needed to confirm these associations in larger studies.

More Related Videos

A Protocol for Constructing a Rat Wound Model of Type 1 Diabetes05:18

A Protocol for Constructing a Rat Wound Model of Type 1 Diabetes

Published on: February 17, 2023

A Mouse Model of Hemorrhagic Transformation Induced by Acute Hyperglycemia Combined with Transient Focal Ischemia09:35

A Mouse Model of Hemorrhagic Transformation Induced by Acute Hyperglycemia Combined with Transient Focal Ischemia

Published on: November 15, 2024

Related Concept Videos

Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...